Avid Bioservices Inc (CDMO)

[Protector]

I like that you ask the question because it is about the only question that can be asked to throw some doubt over PPHM.

Were it not of course that today we have a complete scientific community behind the PS targeting of witch PPMH holds the 100% IP right unencumbered and which can of course only start to turn into PPS appreciation when the first entities start to use the IP.

Today we have 24+ collaborations, partnership talk on-going, and apparently a number of companies that are prepared to invest in PPHMP at 25$ per share or 3$ per common share at an 8.33 conversion rate for an interest rate of 10.5% or 3% higher that the last loan but NO capital payback stress, and no more loan terms.

So apparently the market is waiting for the first COMMERCIAL grade event let the PPS go to the sky. 1500+ papers on PS-targeting and several peer-reviews and good clinical trial results is insufficient. The market needs events that point to INCOME (OK, Avid is big income at about 50% gross but insufficient to sponsor everything and it is not that kind of income they are waiting for).

So A PIII approval, a gov deal, a partnership, a partial buy-out, licensing, or even acquisition offers at some point are the events the market is waiting for because EACH of them end with revenue.